Development of warm autoimmune hemolytic anemia after initiation of Ruxolitinib in a patient with STAT1 gain-of-function mutation

被引:1
|
作者
Hartono, Stella [1 ]
Agharahimi, Anahita [2 ]
Tauk, Silpa [3 ]
Bosticardo, Marita [2 ]
Mangat, Mona [4 ]
Pfister, Justina [5 ]
Notarangelo, Luigi [6 ]
Leiding, Jennifer [7 ]
Freeman, Alexandra [6 ]
机构
[1] NIAID, Bethesda, MD USA
[2] NIH, Bethesda, MD USA
[3] Univ S Florida, Tampa, FL USA
[4] Bay Area Allergy & Asthma, Allergy Immunol, Berkeley, CA USA
[5] NIAID, Primary Immunodeficiency Clin, Bethesda, MD USA
[6] NIAID, NIH, Bethesda, MD USA
[7] Johns Hopkins South Florida, St Petersburg, FL USA
关键词
STAT1; gain-of-function; Ruxolitinib; Autoimmune hemolytic anemia; Sirolimus;
D O I
10.1016/j.clim.2023.109413
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
66
引用
收藏
页码:29 / 29
页数:1
相关论文
共 50 条
  • [1] Utility of ruxolitinib in a patient with chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation
    Olivier, N.
    Boralevi, F.
    Fricain, J. -C.
    Doutre, M. -S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (11) : E899 - E902
  • [2] Aortic Calcification in a Patient with a Gain-of-Function STAT1 Mutation
    Smyth, Anna E.
    Kaleviste, Epp
    Snow, Aisling
    Kisand, Kai
    McMahon, Colin J.
    Cant, Andrew J.
    Leahy, T. Ronan
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (04) : 468 - 470
  • [3] Aortic Calcification in a Patient with a Gain-of-Function STAT1 Mutation
    Anna E. Smyth
    Epp Kaleviste
    Aisling Snow
    Kai Kisand
    Colin J. McMahon
    Andrew J. Cant
    T. Ronan Leahy
    Journal of Clinical Immunology, 2018, 38 : 468 - 470
  • [4] Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation
    Kunihiko Moriya
    Tasuku Suzuki
    Nao Uchida
    Tomohiro Nakano
    Saori Katayama
    Masahiro Irie
    Takeshi Rikiishi
    Hidetaka Niizuma
    Satoshi Okada
    Kohsuke Imai
    Yoji Sasahara
    Shigeo Kure
    International Journal of Hematology, 2020, 112 : 258 - 262
  • [5] Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation
    Moriya, Kunihiko
    Suzuki, Tasuku
    Uchida, Nao
    Nakano, Tomohiro
    Katayama, Saori
    Irie, Masahiro
    Rikiishi, Takeshi
    Niizuma, Hidetaka
    Okada, Satoshi
    Imai, Kohsuke
    Sasahara, Yoji
    Kure, Shigeo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (02) : 258 - 262
  • [6] Gain-of-function STAT1 mutation and visceral leishmaniasis
    Lyra, Paula Teixeira
    Augusto Moura Falcao, Ana Carla
    Cruz, Rafael Amora
    Campos Coelho, Antonio Victor
    Souza, Edvaldo da Silva
    Arraes de Alencar, Luiz Claudio
    Oliveira, Joao Bosco
    EINSTEIN-SAO PAULO, 2022, 20 : eRC0048
  • [7] Orf Infection in a Patient with Stat1 Gain-of-Function
    Kilic, Sara Sebnem
    Puel, Anne
    Casanova, Jean-Laurent
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (01) : 80 - 83
  • [8] Myocarditis in a congenital STAT1 gain-of-function patient
    Roosens, Willem
    Staels, Frederik
    Herrero, Cecilia Iglesias
    Gijsbergs, Rik
    Moens, Leen
    Bossuyt, Xavier
    Bogaert, Jan
    Meyts, Isabelle
    Van Aelst, Lucas
    Schrijvers, Rik
    CLINICAL IMMUNOLOGY, 2023, 250 : 31 - 32
  • [9] Orf Infection in a Patient with Stat1 Gain-of-Function
    Sara Sebnem Kilic
    Anne Puel
    Jean-Laurent Casanova
    Journal of Clinical Immunology, 2015, 35 : 80 - 83
  • [10] Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation
    Markéta Bloomfield
    Veronika Kanderová
    Zuzana Paračková
    Petra Vrabcová
    Michael Svatoň
    Eva Froňková
    Martina Fejtková
    Radana Zachová
    Michal Rataj
    Irena Zentsová
    Tomáš Milota
    Adam Klocperk
    Tomáš Kalina
    Anna Šedivá
    Journal of Clinical Immunology, 2018, 38 : 589 - 601